(2Z)-2-{[3-(5-bromo-1-ethyl-1H-indol-3-yl)-1-(4-chlorophenyl)-1H-pyrazol-5-yl]imino}-1,3-thiazolidin-4-one

ID: ALA5287241

Max Phase: Preclinical

Molecular Formula: C22H17BrClN5OS

Molecular Weight: 514.84

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CCn1cc(-c2cc(/N=C3/NC(=O)CS3)n(-c3ccc(Cl)cc3)n2)c2cc(Br)ccc21

Standard InChI:  InChI=1S/C22H17BrClN5OS/c1-2-28-11-17(16-9-13(23)3-8-19(16)28)18-10-20(25-22-26-21(30)12-31-22)29(27-18)15-6-4-14(24)5-7-15/h3-11H,2,12H2,1H3,(H,25,26,30)

Standard InChI Key:  IBGOCTQTYRHZLN-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 31 35  0  0  0  0  0  0  0  0999 V2000
   -0.1768    0.2131    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6481    0.2131    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.8982   -0.5907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.2447   -1.0614    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4226   -0.5695    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.6948   -0.8042    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9083   -1.6008    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.7049   -1.8143    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7384   -2.6553    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9856   -2.9407    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4684   -2.2931    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.4527   -3.0677    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2192   -0.7830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4327   -1.5795    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2737   -1.6131    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5592   -0.8602    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9114   -0.3431    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.3283   -0.5583    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.4527    0.2612    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8094    0.7772    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.0363    0.4798    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0604    0.9274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6483    1.6418    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0600    2.3535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8850    2.3535    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2967    1.6436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8887    0.9274    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6861   -2.3273    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.0228    1.5739    0.0000 Br  0  0  0  0  0  0  0  0  0  0  0  0
   -2.2737   -3.0415    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.2974    3.0677    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  2  0
  1  5  2  0
  5  4  1  0
  3  6  1  0
  6  7  2  0
  8  7  1  0
  8  9  1  0
  9 10  1  0
 11 10  1  0
  7 11  1  0
  9 12  2  0
  5 13  1  0
 14 13  2  0
 14 15  1  0
 15 16  1  0
 17 16  2  0
 13 17  1  0
 16 18  1  0
 19 18  2  0
 20 19  1  0
 21 20  2  0
 17 21  1  0
  2 22  1  0
 23 22  2  0
 24 23  1  0
 25 24  2  0
 26 25  1  0
 27 26  2  0
 22 27  1  0
 15 28  1  0
 20 29  1  0
 28 30  1  0
 25 31  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5287241

    ---

Associated Targets(Human)

BEAS-2B (690 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A549 (127892 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SK-MEL-28 (48833 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

B16-F10 (4610 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 514.84Molecular Weight (Monoisotopic): 513.0026AlogP: 5.78#Rotatable Bonds: 4
Polar Surface Area: 64.21Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 7.57CX Basic pKa: 0.79CX LogP: 6.04CX LogD: 5.82
Aromatic Rings: 4Heavy Atoms: 31QED Weighted: 0.38Np Likeness Score: -1.52

References

1. Soni JP, Chilvery S, Sharma A, Reddy GN, Godugu C, Shankaraiah N..  (2023)  Design, synthesis and in vitro cytotoxicity evaluation of indolo-pyrazoles grafted with thiazolidinone as tubulin polymerization inhibitors.,  14  (3): [PMID:36970141] [10.1039/d2md00442a]

Source